Posted on 12/14/16
Tekla World Healthcare Fund Announces Renewal of Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Tekla World Healthcare Fund (NYSE: THW) announced today that the Board of Trustees authorized a renewal of its share repurchase program. The share repurchase program . . .
Posted on 12/13/16
Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN)
Posted on 12/13/16
The 3 Most Profit-Friendly Biotech Stocks
Developing game-changing medicine isn't easy, and it's certainly not cheap. It can cost hundreds of millions of dollars to create new drugs, and with a clinical . . .
Posted on 12/13/16
Here's Why Trump's Pledge to Lower Drug Prices Is All Bark and No Bite
IMAGE SOURCE: DISNEY-ABC TELEVISION GROUP VIA FLICKR.In less than six weeks, President-elect Donald Trump will be inaugurated and become the 45th president of the United States. . . .
Posted on 12/13/16
Purdue Pharma and Exicure Announce Strategic Research Collaboration Agreement
STAMFORD, Conn. & SKOKIE, Ill.--(BUSINESS WIRE)--Purdue Pharma L.P. and Exicure, Inc. today announced a strategic research collaboration, option and license agreement to discover and develop a . . .
Posted on 12/13/16
Arteriocyte Announces Name Change to Compass Biomedical
Arteriocyte, Inc., the research and development division of the Arteriocyte family of companies, announced today that they will begin doing business as Compass Biomedical. The name . . .
Posted on 12/13/16
Indiana University to Use EYE-SYNC by SyncThink to Study Subconcussive Head Impacts
SyncThink, a world leader in neuro-technology, announces today that its first medical device EYE-SYNC, will be used at Indiana University for a study on sub-concussive head . . .
Posted on 12/12/16
Better Buy: Amgen Inc. vs. Biogen
Two of the biggest biotechs in the world haven't exactly had a great 2016. Shares of Amgen(NASDAQ:AMGN) and Biogen (NASDAQ:BIIB) are both down year to date. . . .
Posted on 12/12/16
Better Buy: bluebird bio, Inc. vs. Kite Pharma
Several clinical-stage biotechs are developing therapies using chimeric antigen receptor T cells (CAR-T). Two of them in particular have enjoyed some good news in 2016: bluebird . . .
Posted on 12/11/16
Alzheon Presents Analyses from Phase 3 Clinical Studies Showing Largest Clinical Effects of Tramiprosate
Results Support ‘Precision Medicine’ Approach in Alzheimer’s Drug Development and Pivotal Study of ALZ-801 in Genetically-Defined Patients with Mild Alzheimer’s Disease to Begin in 2017Clinical Data . . .
Posted on 12/9/16
The 3 Best Biotech Stocks for 2017
Trying to pick the best biotech stocks for 2017 -- defined as those with the best returns -- is a bit of a crapshoot. The biotech . . .
Posted on 12/9/16
Here's Why Radius Health Dropped 12% Today Despite Positive Clinical Results
IMAGE SOURCE: GETTY IMAGES. What happenedInvestors of Radius Health (NASDAQ:RDUS) may be a bit confused Thursday after the company reported positive data in two phase 1 . . .
Posted on 12/8/16
Nationwide Children's Hospital Joins the TriNetX Health Research Network
TriNetX, the health research network, announced today that Nationwide Children's Hospital signed a membership agreement to join the network to enhance and accelerate the development of . . .
Posted on 12/8/16
2 Reasons Why Alnylam Pharmaceuticals Stock Gained 18.5% in November
What happenedAccording to data from S&P Global Market Intelligence, shares of the leading RNA interference drugmaker Alnylam Pharmaceuticals (NASDAQ:ALNY) gained 18.5% last month. The biotech's stock . . .
Posted on 12/8/16
Simpson Healthcare Executives Honored as 2016 eHealthcare Leadership Awards Winner at the 20th Annual Healthcare Internet Conference
Simpson Healthcare Executives, a global leader in biopharmaceutical consulting, announced that they received a highly competitive Award of Distinction from the eHealthcare Leadership Awards program for . . .
Posted on 12/8/16
Fulcrum Therapeutics Appoints Renowned Experts in CNS Disorders and Muscular Dystrophies
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control, today announced that it has formed a Scientific . . .
Posted on 12/6/16
Read This Before You Buy Biotech Stocks
Plenty of growth investors flock to biotech stocks because the industry can provide eye-popping gains. For example, shares of Tesaro (NASDAQ:TSRO) more than doubled after the . . .
Posted on 12/6/16
The Main Reason Achillion Pharmaceuticals, Inc. Collapsed 34% in November
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Achillion Pharmaceuticals (NASDAQ:ACHN), a developmental-stage developer of small-molecule drugs to treat autoimmune diseases and infectious diseases such as hepatitis C, . . .
Posted on 12/5/16
Cigna Earns Top Marks in 2017 Corporate Equality Index for 5th Consecutive Year
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna (NYSE: CI), a health service company, proudly announced that it received a perfect score of 100 on the 2017 Corporate Equality Index (CEI), . . .
Posted on 12/5/16
Why Bristol-Myers Squibb Co. Stock Surged in November
IMAGE SOURCE: GETTY IMAGES.What happenedAccording to data from S&P Global Market Intelligence, Bristol-Myers Squibb's (NYSE:BMY) stock climbed higher by more than 11% last month. This double-digit . . .
Posted on 12/5/16
Does Pfizer Pass Warren Buffett’s Test?
Warren Buffett has a long and storied history of using Berkshire Hathaway's financial might to make earth-shattering acquisitions. Over the years he has spent tens of . . .
Posted on 12/5/16
This Trump Appointment Likely Spells Imminent Doom for Obamacare
IMAGE SOURCE: GETTY IMAGES.The Affordable Care Act as we know it could be on its last legs.The ACA, which is more commonly known as Obamacare, transformed . . .
Posted on 12/4/16
Magenta Therapeutics Cofounder David Scadden Honored at the American Society of Hematology Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, a biotechnology company harnessing the power of stem cell science to revolutionize hematopoietic stem cell transplantation for patients with blood-based and immunologic . . .
Posted on 12/4/16
Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 12/4/16
Promedior Announces Completion of Patient Enrollment Milestones in Phase 2 Clinical Studies of PRM-151
—Successful Enrollments Advance Promedior's Novel Clinical Candidate with Disease-Modifying Potential—Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced . . .
Boston
